Medical experts warned that obesity and Type 2 diabetes continue to be under-treated in the Philippines, calling for earlier intervention and urgent, coordinated care as the number of affected Filipinos rises. Latest available figures cited during the discussion show that diabetes affects about 7.5% of Filipino adults, or an estimated 4.7 million people. At the same time, nearly 60% of adults are either overweight or obese, conditions that significantly increase the risk of developing Type 2 diabetes. Cummings explained how newer therapies aim to address both metabolic and neurological pathways involved in obesity and diabetes. Beyond health outcomes, the discussion also highlighted the economic impact of obesity and diabetes.